Research Roundup

Debbie Rigby rounds up the latest research news Lipoprotein(a): Actionable today, treatable tomorrow? Lipoprotein(a) (Lp(a)) is an atherogenic, low-density lipoprotein (LDL)-like particle whose concentrations, mostly genetically determined, are elevated in about 20% of individuals. It is a major and under-recognised independent risk factor for atherosclerotic cardiovascular disease (ASCVD) and aortic valve stenosis. Australian Journal of General